Risperdal Jury “Blown Away” By Testimony On Study Manipulation; J&J Settles Texas Suit

In the midst of a trial, Johnson & Johnson agrees to pay $158 million to settle a suit by the state of Texas alleging the company promoted Risperdal off-label to children. Two states previously won jury verdicts over the company’s marketing of the antipsychotic.